Product NDC: | 76282-212 |
Proprietary Name: | SERTRALINE |
Non Proprietary Name: | Sertraline |
Active Ingredient(s): | 25 mg/1 & nbsp; Sertraline |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76282-212 |
Labeler Name: | Exelan Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077397 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120820 |
Package NDC: | 76282-212-05 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (76282-212-05) |
NDC Code | 76282-212-05 |
Proprietary Name | SERTRALINE |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (76282-212-05) |
Product NDC | 76282-212 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sertraline |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120820 |
Marketing Category Name | ANDA |
Labeler Name | Exelan Pharmaceuticals, Inc. |
Substance Name | SERTRALINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |